Introduction {#s1}
============

Acute kidney injury (AKI) occurs with an incidence ranging between 30% and 70% in critically ill patients [@pone.0070482-Hoste1]. Despite several recent advances in AKI assistance, such as refined dialysis support, better dialysis adequacy, volume and fluid management, improved diagnosis and treatment of AKI-related distant organ dysfunction, AKI morbidity and mortality rates remain unacceptably elevated [@pone.0070482-Cerda1]--[@pone.0070482-Schrier1].

An important contribution for the understanding of AKI was the introduction of RIFLE and AKIN criteria [@pone.0070482-Bellomo1], [@pone.0070482-Mehta1]. These indices provide a universal AKI definition that allows comparisons among clinical studies worldwide [@pone.0070482-Ricci1]. In addition, the search for earlier and more sensitive renal biomarkers has contributed to a new perspective on early AKI diagnosis and timely interventions [@pone.0070482-Devarajan1], [@pone.0070482-Koyner2].

In view of this new AKI clinical approach, early nephrology consultation could provide opportunities for intervention and modification of AKI patients\' outcomes. In a pioneer study, Mehta *et al.* reported that delayed nephrology consultation (NC) was associated with increased mortality in critically ill AKI patients but this result was not sustained after adjustment for confounding variables [@pone.0070482-Mehta2]. Recent reports have indicated that early NC may improve hospital-acquired AKI prognosis, although none of these studies have assessed a large group of AKI intensive care unit (ICU) patients [@pone.0070482-Balasubramanian1]--[@pone.0070482-Meier1]. Additionally, other important aspects, such as determining factors for nephrology referral and optimal time for renal consultation remain to be determined [@pone.0070482-Mehta3].

Therefore, the aims of this study were to analyze the determining factors for nephrology referral and evaluate the hypothesis that timing of nephrology consultation may influence the prognosis of AKI patients in the ICU. We hypothesized that delayed NC could be associated with higher mortality and dialysis dependence at hospital discharge.

Materials and Methods {#s2}
=====================

Study participants: A prospective, observational study was conducted through an active search for AKI cases by daily visits to six ICUs (pulmonary, internal medicine, trauma, surgical, infectious diseases and emergency) comprising 53 beds at Hospital das Clinicas of the University of São Paulo, a tertiary academic institution in Brazil.

The study protocol was approved by the Hospital das Clinicas of University of Sao Paulo ethics and research committee. An informed consent, either verbal or written, was not required because of the observational nature of the study with critically ill patients in the ICU. The CAPPesq - Comissao de Etica para Analise de Projetos de Pesquisa do Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, local ethics and review board waived the need for written informed consent from the participants of the study.

All patients admitted to the selected ICUs were evaluated for AKI during ICU stay, between November 2003 and June 2005. All AKI patients were prospectively followed since AKI diagnosis day until hospital discharge or death. AKI was defined as an increase ≥50% from baseline serum creatinine (SCr), according to the RISK stage of the RIFLE system [@pone.0070482-Bellomo1]. Sepsis was defined according to established criteria [@pone.0070482-Levy1]. Chronic kidney dysfunction (CKD) was considered with an estimated Cr clearance \<60 ml/min/1.73 m^2^ (NKF stage ≥III). Surgical AKI was considered as an AKI related to surgical procedures. The exclusion criteria were baseline SCr≥3.0 mg/dL, dialysis treatment, age \<18 years old, kidney transplantation, ICU stay shorter than 48 h, AKI diagnosis established more than 24 h before ICU admission, urinary tract obstruction, and hypovolemia responsive to fluids. Nephrology consultation (NC) was classified as early or delayed NC if they occurred before or more than 48 h after the AKI diagnosis day, respectively [@pone.0070482-Mehta2].

In order to guarantee the observational character of the study, data were collected by a single observer, independent of the ICU and nephrology staff, who was not involved in patient care. Nephrology referral was kept by the ICU attending physician discretion. The attending nephrologists run daily rounds and are available 24 h/day. Thus, NC was usually performed immediately after ICU call. Nephrology service is responsible for dialysis support but decisions on dialysis indications are taken together by the ICU and nephrology physicians. The primary outcomes were in-hospital mortality and dialysis dependence at hospital discharge. Hospital and ICU length of stay were also recorded.

The following variables were collected: age, sex, race, hospital and ICU admission days, ICU origin, co-morbidities (assessed by Charlson co-morbidity Index) [@pone.0070482-Charlson1], baseline renal function, presumed AKI etiologies, vital signs, urine output, laboratory tests, vasoactive drug use and mechanical ventilation. Intermittent hemodialysis was defined as dialysis performed for up to 8 hours of duration (Fresenius 4008S, Germany) and continuous renal replacement therapy as continuous venous-venous hemodialysis (CVVHD), prescribed for at least 24 h (Diapact BBraun, Brazil). Illness severity was assessed with the Simplified Acute Physiology Score (SAPS) 3 with the customized equation for the Central and South America (CSA) region [@pone.0070482-CostaeSilva1]. Organ failure was defined as follows: a) respiratory -- need of mechanical ventilation; b) central nervous system (CNS) -- Glasgow coma scale ≤8; c) hepatic -- total bilirubin ≥2.0 mg/dL and/or enzymatic activity (prothrombin time) ≤50%; d) hematological -- leukocytes ≤1,000/mm^3^ and/or platelets ≤20,000 and/or hematocrit ≤20%; and e) cardiovascular -- cardiovascular SOFA score ≥3 [@pone.0070482-Vincent1].

Statistical analysis: Data were expressed as mean ± SD or median with 25^th^ and 75^th^ interquartile ranges (IQR) as appropriate. Categorical variables were expressed as proportions and were analyzed with Pearson\'s χ^2^ test for independent groups. Fisher\'s test was used where appropriate. Multivariable logistic regression models were constructed with backwards variable selection, using *P*-value \<0.05 for variable retention. Candidate variables were those with a likelihood ratio of significance \<0.05 upon bivariate analysis. The colinearity of the maximal models was evaluated using the criteria proposed by Belsley [@pone.0070482-Belsley1]. Discrimination was assessed using the AUCROC [@pone.0070482-Hanley1]. Calibration was assessed using the Hosmer-Lemeshow (HL) goodness-of-fit test comparing observed vs. expected mortality across deciles of risk [@pone.0070482-Hosmer1]. A high *P*-value (\>0.05) indicated a good fit of the model.

To address the influence of confounding variables, covariate adjusted propensity scores (PS) were utilized [@pone.0070482-Austin1]--[@pone.0070482-Rubin1]. A PS for delayed versus early NCs was created with the variables obtained on the AKI diagnosis day. Additionally, a PS for nephrology consultation (yes or no) was created with the variables obtained on the day of the NC or on the third day after AKI diagnosis for those not evaluated by nephrology. A multivariable logistic regression model was generated using factors that differed among groups (*P*\<0.05) and a model predicting the likelihood or "propensity" of consultation was fitted. Propensity scores were then incorporated as covariates in a logistic regression model, using mortality as the dependent variable.

A two-tailed *P*-value \<0.05 was considered significant. Statistical analysis was carried out using SPSS for Windows, version 18.0 (Chicago, IL, USA), and SAS (SAS Institute, Cary, NC, USA).

Results {#s3}
=======

During the study period, a total of 2,998 patients were admitted to the selected ICUs. Among these patients, AKI was diagnosed in 400 patients. Only 34 patients (8.5%) were excluded because of missing data, resulting in 366 AKI patients suitable for analysis. NC was performed in 53.6% (196/366) of the AKI patients and occurred 3.0 (1.0--4.0) days after the AKI diagnosis day (DD). Most patients referred to nephrologists were subjected to early NC (65.3%) ([Figure 1](#pone-0070482-g001){ref-type="fig"}). The overall hospital mortality was 67.8% (248/366) and dialysis was required in 31.4% (115/366) of patients.

![Flowchart of study population.\
ICU: intensive care unit; AKI: acute kidney injury; NC: nephrology consultation.](pone.0070482.g001){#pone-0070482-g001}

Nephrology Consultation {#s3a}
-----------------------

Patients referred to nephrologists presented higher mortality (OR: 2.96/CI: 1.87--4.67) and decreased hospital length of stay compared with patients not evaluated by nephrologists (18.5 \[11.0--36.0\] vs. 27.50 \[14.0--37.0\] days, P\<0.0001). When these two groups (NC and non-NC) were compared on the day of nephrology consultation (day 3), several differences were observed. NC patients demonstrated increased illness severity assessed by organ failures and SAPS3 scores, as well as with parameters related to AKI severity (reduced diuresis and serum bicarbonate \[SBic\]); increased SCr, blood urea nitrogen and potassium \[SK\] ([Table 1](#pone-0070482-t001){ref-type="table"}). A propensity score (PS) for NC was created. The five variables retained in the model were: SAPS 3, CSA score, diuresis, SCr, SK, and SBic ([Table 2](#pone-0070482-t002){ref-type="table"}). After correction by the PS, NC was no longer associated with increased mortality (OR: 1.21/CI: 0.66--2.19).

10.1371/journal.pone.0070482.t001

###### Patients\' characteristics according to nephrology consultation status.

![](pone.0070482.t001){#pone-0070482-t001-1}

                                                                         NC                   No NC          
  ------------------------------------------------------------ ---------------------- ---------------------- ----------
  Age (years)                                                         58±18.4                56±19.3           0.320
  Male sex                                                           125 (63.8)             93 (54.7)          0.078
  Caucasian                                                          135 (68.9)             118 (69.4)         0.912
  Surgical AKI                                                       42 (21.4)              44 (25.9)          0.316
  Sepsis                                                             137 (69.9)             107 (62.9)         0.159
  CKDFCIII                                                           61 (31.1)              32 (18.8)          0.007
  Charlson Comorbidity Index[1](#nt102){ref-type="table-fn"}       2.0 (1.0--4.0)        2.0 (1.0--3.25)       0.260
  Number of organ system failures                                  3.0 (2.0--4.0)         2.0 (1.0--3.0)      \<0.0001
  Cardiovascular                                                     105 (53.6)             53 (31.2)         \<0.0001
  Respiratory                                                        166 (84.7)             117 (68.8)        \<0.0001
  Hepatic                                                            107 (54.6)             73 (42.9)          0.026
  Neurologic                                                         110 (56.1)             74 (43.5)          0.016
  Hematologic                                                        24 (12.2)               9 (5.3)           0.038
  SAPS 3 CSA[2](#nt103){ref-type="table-fn"}                         69.7±23.8              53.5±28.5         \<0.0001
  Serum creatinine (mg/dL)                                         3.2 (2.3--4.3)         1.7 (1.3--2.3)      \<0.0001
  Maximum Serum creatinine (mg/dL)                               4.30 (3.20--5.30)      2.40 (1.80--3.20)     \<0.0001
  Blood Urea nitrogen (mg/dL)                                       55 (38--77)             37(23--51)        \<0.0001
  Diuresis (ml/24 h)                                              575 (200--1195)        1645 (937--2662)     \<0.0001
  Oliguria (diuresis \< 400 ml/24 h)                                 75 (38.3)               17 (10)          \<0.0001
  Furosemide use (yes/no)                                            76 (38.8)              35 (20.6)         \<0.0001
  RIFLE Stage                                                                                                
  Risk                                                               21 (10.7)              40 (23.5)          0.001
  Injury                                                             55 (28.1)              63 (37.1)          0.066
  Failure                                                            112 (57.1)             37 (21.8)         \<0.0001
  Serum bicarbonate (mEq/L)                                        15.0 (13--18)           18 (15--21)        \<0.0001
  Serum sodium (mEq/L)                                             141 (136--146)         142 (138--145)       0.314
  Serum potassium (mEq/L)                                          4.9 (4.0--5.5)         4.0 (3.5--4.6)      \<0.0001
  Total Bilirubin (mg/dL)                                          0.9 (0.5--2.5)         0.7 (0.4--1.5)       0.055
  GOT (UI/dL)                                                       42 (26--99)            36 (21--60)         0.015
  Pre-AKI ICU LOS (days)                                           1.0 (0.0--4.0)         1.0 (0.0--7.0)       0.575
  Pre-ICU LOS (days)[3](#nt104){ref-type="table-fn"}             4.00 (1.00--14.00)     3.00 (1.00--9.00)      0.268
  Dialysis[4](#nt105){ref-type="table-fn"}                           115 (58.7)                 0             \<0.0001
  Time in mechanical ventilation (days)                         12.00 (7.00--19.75)    10.00 (4.00--24.25)     0.149
  ICU LOS (days)                                                16.00 (10.00--25.00)   17.00 (11.00--39.00)    0.066
  Hospital LOS (days)                                           18.50 (11.00--36.00)   27.50 (14.00--37.00)   \<0.0001
  Mortality                                                          154 (78.6)             90 (55.3)         \<0.0001

Results are expressed in number (%), mean ± SD or median (25--75 IQR).

Age points were suppressed.

Mortality probability.

After hospital admission.

Dialysis was exclusively performed by nephrologists.

SD, standard deviation; IQR, interquartile range; CKDFCIII, chronic kidney disease functional class III; SAPS, simplified acute physiology score; CSA, customized equation for countries from Central and South America; GOT, aspartate aminotransferase; LOS, length of stay, AKI, acute kidney injury; ICU, intensive care unit.

10.1371/journal.pone.0070482.t002

###### Variables retained in the propensity score model for nephrology consultation (*P*\<0.05)[\*](#nt107){ref-type="table-fn"}.

![](pone.0070482.t002){#pone-0070482-t002-2}

                                                                 *P*         OR (95% CI)
  ----------------------------------------------------------- ---------- -------------------
  SAPS 3 CSA[1](#nt108){ref-type="table-fn"}                    0.002     1.17 (1.06--1.30)
  SCr (mg/dL)                                                  \<0.0001   2.34 (1.78--3.08)
  Diuresis (1000 ml/24 h)                                      \<0.001    0.74 (0.58--0.93)
  Serum potassium (mEq/L)                                       0.037     1.36 (1.01--1.84)
  Serum bicarbonate (mEq/L)[2](#nt109){ref-type="table-fn"}     0.037     0.53 (0.29--0.96)

Model performance: area under ROC curve = 0.86 (0.82--0.90); Hosmer-Lemeshow χ^2^ = 0.29.

Each 10 units.

Each 10 mEq/L.

ROC, receiver operating characteristic; SAPS, simplified acute physiology score; CSA, customized equation for countries from Central and South America; SCr, serum creatinine level; OR, odds ratio; CI, confidence interval.

Nephrology Consultation Timing -- Factors associated with Delayed Nephrology Consultation {#s3b}
-----------------------------------------------------------------------------------------

AKI diagnosis occurred 1.0 (0.00--4.00) day after ICU admission while NC occurred 3.0 (1.0--4.0) days after the AKI DD. Median time for nephrology referral was 5.5 (4.0--9.0) and 1.0 (0.0--2.0) days in delayed and early NC groups, respectively.

The early and delayed NC groups presented differences, especially regarding AKI origin and renal function on the AKI diagnosis day. There were no differences in demographic (age, co-morbidities) or illness status characteristics (sepsis, organ failure -- except mechanical ventilation, severity scoring) between the groups ([Table 3](#pone-0070482-t003){ref-type="table"}). A propensity score for delayed NC was created. The variables retained in the model were diuresis, SCr, surgical AKI and mechanical ventilation ([Table 4](#pone-0070482-t004){ref-type="table"}).

10.1371/journal.pone.0070482.t003

###### Patients\' characteristics comparing delayed and early nephrology consultation (NC) groups on AKI diagnosis day.

![](pone.0070482.t003){#pone-0070482-t003-3}

                                                                   Delayed NC           Early NC       
  ------------------------------------------------------------ ------------------- ------------------- ----------
  Age (years)                                                         60±18              56±18.4          0.20
  Male sex                                                          46 (67.6)           79 (61.7)         0.41
  White                                                             48 (70.6)           87 (68.0)         0.70
  Surgical AKI                                                      23 (33.8)           19 (14.8)         0.02
  Sepsis                                                            47 (69.1)           90 (70.3)         0.86
  CKDFCIII                                                          22 (32.4)           39 (30.5)         0.78
  Charlson Comorbidity Index[1](#nt112){ref-type="table-fn"}     5.0 (3.0--6.0)      4.0 (2.0--6.0)      0.301
  Number of organ system failures                                3.0 (2.0--4.0)      3.0 (2.0--4.0)      0.421
  Cardiovascular                                                    59 (86.8)          103 (80.5)        0.128
  Respiratory                                                       61 (89.7)           91 (71.1)        0.030
  Hepatic                                                           37 (54.4)           70 (54.7)        0.971
  Neurologic                                                        36 (52.9)            64 (50)         0.695
  Hematologic                                                        5 (7.4)            19 (14.8)        0.023
  SAPS 3 CSA[2](#nt113){ref-type="table-fn"}                        60.7±28.5           60.6±26.0        0.645
  Serum creatinine (mg/dL)                                       1.8 (1.5--2.3)      2.4 (1.8--3.4)     \<0.0001
  Maximum Serum creatinine (mg/dL)                              4.30 (3.31--5.10)   4.20 (3.12--5.30)    0.996
  Blood Urea nitrogen (mg/dL)                                      33 (23--44)         41 (27--63)       0.003
  Diuresis (ml/24 h)                                            1245 (672--1745)     625 (250--1257)    \<0.0001
  Oliguria (diuresis \<400 ml/24 h)                                  6 (8.8)            48 (37.5)       \<0.0001
  Furosemide use (yes/no)                                            17 (25)            37 (28.9)         0.56
  RIFLE Stage                                                                                          
  Risk                                                              41 (60.3)           44 (34.4)       \<0.0001
  Injury                                                            21 (30.9)           39 (30.5)        0.952
  Failure                                                            6 (8.8)            45 (35.1)       \<0.0001
  Serum bicarbonate (mEq/L)                                        18 (15--21)        15.7 (13--19)     \<0.0001
  Serum sodium (mEq/L)                                           140 (136--144)      140 (136--144)       0.74
  Serum potassium (mEq/L)                                        4.6 (3.8--5.2)      4.7 (4.0--5.4)       0.13
  Total bilirubin (mg/dL)                                        0.8 (0.5--2.1)      1.0 (0.5--2.6)       0.28
  GPT (UI/dL)                                                      22 (15--50)         31 (17--78)        0.03
  Pre-AKI ICU LOS (days)                                         2.0 (0.5--8.0)      1.0 (0.0--3.0)     \<0.001
  Pre-ICU LOS (days)[3](#nt114){ref-type="table-fn"}             6.5 (1.0--18.5)     4.0 (1.0--11.5)     0.061
  Dialysis                                                           34 (50)            81 (63.3)        0.072
  Time in mechanical ventilation (days)                         16.5 (11.0--32.0)   10.0 (6.00--15.0)   \<0.0001
  ICU LOS (days)                                                19.0 (12.5--34.5)   13.5 (9.00--23.0)     0.03
  Hospital LOS (days)                                           20.0 (13.0--36.5)   18.0 (11.0--36.0)    0.493
  Dialysis dependence                                               57 (83.8)           81 (63.3)        0.003
  Mortality                                                         62 (91.2)           92 (71.9)        0.002

Results are expressed in number (%), mean ± SD or median (25--75 IQR).

Age points were suppressed.

Mortality probability.

After hospital admission; SD, standard deviation; IQR, interquartile range; CKDFCIII, chronic kidney disease functional class III; ICU, intensive care unit; CRRT, continuous renal replacement therapy; AKI, acute kidney injury; LOS, length of stay; SAPS, simplified acute physiology score; CSA, customized equation for countries from Central and South America; GPT, alanine aminotransferase.

10.1371/journal.pone.0070482.t004

###### Variables retained in the propensity score model for delayed nephrology consultation (*P*\<0.05)[\*](#nt115){ref-type="table-fn"}.

![](pone.0070482.t004){#pone-0070482-t004-4}

                               *P*        OR (95% CI)
  ------------------------- --------- -------------------
  SCr (mg/dL)                 0.001    0.51 (0.35--0.76)
  Diuresis (1000 ml/24 h)    \<0.001   2.24 (1.46--3.43)
  Surgical patients           0.001    3.67 (1.65--8.15)
  Mechanical ventilation      0.036    2.82 (1.06--744)

Model performance: area under ROC curve = 0.79 (0.72--0.85); Hosmer-Lemeshow χ^2^ = 0.48.

ROC, receiver operating characteristic; SCr, serum creatinine level; OR, odds ratio; CI, confidence interval.

Influence of Delayed Nephrology Consultation on patient outcomes {#s3c}
----------------------------------------------------------------

The delayed NC group presented higher mortality (OR: 4.04/CI: 1.60--10.17) and increased dialysis dependence at hospital discharge (OR: 3.00/CI: 1.43--6.29). After correction by the PS, delayed NC was still associated with higher mortality (OR: 3.39/CI: 1.24--9.29) and greater dialysis dependence (OR: 3.25/CI: 1.41--7.51).

Delayed NC patients presented increased ICU length of stay (LOS, days) (19.00 \[12.50--34.50\] compared with the early NC group (13.5 \[9.00--23.00\], P = 0.03). Delayed NC patients needed longer mechanical ventilation support (MV, days)) (16.5 \[11.0--32.0\] compared with the early NC group (10.0 \[6.0--15.0\], P: 0.001, [Table 3](#pone-0070482-t003){ref-type="table"}). Prolonged time on MV was associated with mortality (8.0 \[0.0--18.0\] vs. 12.0 \[8.0--20.2\] for survival and non-survival patients, respectively, P = 0.002).

Dialysis Characteristics Associated with Delayed Nephrology Consultation {#s3d}
------------------------------------------------------------------------

Renal replacement therapy (RRT) was provided exclusively by intermittent hemodialysis (14.7%, 17/115) and CVVHD (87.8%, 104/115). Dialysis was initiated around 4.0 (2.0--7.0) days after AKI DD and 1.0 (0.0--3.0) day after NC. RRT was associated with increased mortality (OR:2.26/CI:1.13--4.53) but RRT requirement was not different in both early and delayed NC groups (P = 0.072).

Time period to start dialysis after NC was not different between early and delayed NC groups (P = 0.054). However, time duration to start dialysis after AKI DD was longer in delayed NC patients (7.0 days \[5.0--11.0\] than in early NC group (2.0 days \[1.0--4.0\], P\<0.0001). Prolonged time for dialysis initiation after AKI diagnosis was associated with mortality (1.00 \[1.0--2.0\] vs. 4.0 \[2.0--8.0\] in survival and non-survival patients, respectively, P = 0.001).

Delayed NC was associated with increased mortality in both dialyzed (31.4%, OR: 1.54/CI: 1.35--1.78) and non-dialyzed patients (OR: 2.89/CI: 1.00--8.35). In addition, delayed NC patients needed longer periods of MV regardless the RRT requirement ([Table 5](#pone-0070482-t005){ref-type="table"}). When dialysis and non-dialysis patients were analyzed on AKI DD, delayed and early NC groups presented similar results: no differences in demographics (age, co-morbidities) or illness status characteristics (sepsis, organ failure, severity scoring). However, early dialyzed NC patients presented worse parameters related to AKI severity such as reduced diuresis and increased SCr ([Table 5](#pone-0070482-t005){ref-type="table"}).

10.1371/journal.pone.0070482.t005

###### Patients characteristics comparing delayed and early Nephrology Consultation (NC) subgroups in both dialyzed and no dialyzed patients on Acute Kidney Injury (AKI) diagnosis day.

![](pone.0070482.t005){#pone-0070482-t005-5}

  Characteristics[\*](#nt117){ref-type="table-fn"}              Dialyzed patients (n = 115)   No dialyzed patients (n = 81)                                                     
  ------------------------------------------------------------ ----------------------------- ------------------------------- ---------- ------------------- ------------------- ----------
  Age (years)                                                             58±18.4                        57±18.3               0.711          57±17.8             57±18.9         0.807
  Male                                                                   73 (63.5)                      51 (63.0)              0.941         25 (73.5)           26 (55.3)        0.094
  Surgical AKI                                                           11 (32.4)                      11 (13.6)               0.02         8 (23.5)            10 (21.3)        0.810
  Sepsis                                                                 82 (71.3)                      55 (67.9)              0.609         23 (67.6)           32 (68.1)        0.967
  CKDFCIII                                                               39 (33.9)                      22 (27.2)              0.315         10 (29.4)           12 (25.5)        0.698
  Charlson Comorbidity Index[1](#nt118){ref-type="table-fn"}          2.0 (1.0--4.0)                 2.0 (1.0--4.0)            0.499      2.0 (1.0--4.0)      2.0 (1.0--4.0)      0.953
  Number of organ system failures                                     3.0 (2.0--4.0)                 2.0 (2.0--4.0)            0.098      3.0 (2.0--4.0)      3.0 (2.0--3.0)      0.392
  Cardiovascular Failure                                                104 (90.4)                      58 (71.6)              0.001         27 (79.4)           31 (66.0)        0.185
  Respiratory Failure                                                    31 (91.2)                      59 (72.8)              0.030         30 (88.2)           32 (68.1)        0.035
  Hepatic                                                                61 (53.0)                      46 (56.8)              0.604         20 (58.8)           26 (55.3)        0.753
  Neurologic                                                             64 (55.7)                      36 (44.4)              0.122         16 (47.1)           20 (42.6)        0.687
  Hematologic Failure                                                     3 (8.8)                       12 (14.8)              0.384          2 (5.9)            7 (14.9)         0.203
  SAPS 3 CSA[2](#nt119){ref-type="table-fn"}                             61.2±28.0                      59.9±24.7              0.095         60.7±26.0           59.3±23.9        0.892
  Serum creatinine (mg/dL)                                            1.9 (1.5--2.5)                 2.5 (1.8--3.6)           \<0.0001    1.7 (1.4--2.3)      2.2 (1.7--3.15)    \<0.0001
  Blood urea nitrogen(mg/dL)                                            38 (28--54)                    48 (31--64)             0.062        28 (21--41)         36 (26--57)       0.069
  Serum bicarbonate (mEq/L)                                          16.9 (14.8--19.6)              14.9 (11.7--17.9)          0.003     16.6 (14.7--18.9)   15.3 (13.7--16.8)    0.113
  Serum potassium (mEq/L)                                             4.7 (3.9--5.5)                4.5 (4.05--5.15)           0.284      4.4 (3.77--5.1)     4.7 (4.2--5.2)      0.283
  Diuresis (ml/24 h)                                                 1050 (710--1500)                560 (190--1000)          \<0.0001   1345 (660--1920)     800 (340--1700)     0.047
  Oliguria (diuresis \<400 ml/24 h)                                       3 (8.8)                       34 (42.0)              0.001          3 (8.8)            14 (29.8)        0.022
  Time to star dialysis after ICU admission (days)                   11.0 (7.0--16.0)               4.00 (2.00--8.00)         \<0.0001          \-                  \-              \-
  Time to start dialysis after AKI diagnosis (days)                   7.0 (5.0--11.0)                2.0 (1.0--4.0)           \<0.0001          \-                  \-              \-
  Time to NC after AKI diagnosis (days)                             6.00 (4.00--10.00)              1.00 (0.00--2.00)         \<0.0001   4.00 (4.00--8.00)   1.00 (0.00--2.00)   \<0.0001
  Time to start dialysis after NC (days)                              1.0 (0.0--2.0)                 1.0 (0.0--3.0)            0.053            \-                  \-              \-
  Pre-AKI ICU LOS (days)                                              1.0 (0.0--6.0)                 0.0 (0.0--3.0)            0.090      3.0 (1.0--11.0)     1.0 (0.0--3.5)      0.002
  Pre-ICU LOS (days)[3](#nt120){ref-type="table-fn"}                  7.0 (1.0--16.0)                3.0 (1.0--8.0)            0.074      5.5 (1.0--19.0)     5.0 (1.0--16.5)     0.516
  Time in mechanical ventilation (days)                              17.0 (11.0--30.0)              11.0 (7.00--16.0)         \<0.0001   15.5 (10.0--35.0)   8.0 (3.50--14.0)    \<0.0001
  ICU LOS (days)                                                     18.5 (11.0--32.0)              13.0 (9.00--22.0)          0.024     19.5 (14.0--38.0)   16.0 (9.00--23.5)    0.073
  Hospital LOS (days)                                                18.5 (11.0--33.0)              16.0 (10.0--36.0)          0.391     22.5 (14.0--48.0)   22.0 (12.5--34.5)    0.550
  Dialysis dependence at hospital discharge                              57 (83.8)                      81 (63.3)              0.003            \-                  \-              \-
  Mortality                                                              34 (100)                       63 (77.8)              0.003         28 (82.4)           29 (61.7)        0.045

Results are expressed in number (%), mean ± SD or median (25--75 IQR).

Age points were suppressed.

Mortality probability.

After hospital admission.

CKDFCIII, chronic kidney disease functional class III; ICU, intensive care unit; AKI, acute kidney injury; LOS, length of stay; SAPS, simplified acute physiology score; CSA, customized equation for countries from Central and South America.

Discussion {#s4}
==========

In this observational study of critically ill patients, it was observed that around half of AKI patients were referred to nephrologists These patients presented higher mortality which probably resulted from patients\' worse illness characteristics (higher SAPS3 score, increased number of organ failures and more severe AKI). However, mortality rate was no longer different between NC and non-NC groups when corrected by the propensity score.

In contrast, a strong association was demonstrated between delayed NC and worse prognosis in NC patients. Mehta *et al.* [@pone.0070482-Mehta2] assessed the impact of NC timing on the prognosis of critically ill AKI patients. Delayed NC was associated with increased mortality in the bivariate analysis but this effect was not sustained after correction by PS. There are similarities compared with our study: ICU setting, similar sample size and PS variables (SCr and diuresis). Conversely, remarkable differences are also present: different AKI definition was utilized because patients were recruited between 1989 and 1995; only patients with AKI diagnosed on ICU admission were enrolled and missing data comprised almost one-third of the initial sample, resulting in only 215 patients out of 822 original AKI NC patients.

Perez-Valdivieso *et al.* [@pone.0070482-PerezValdivieso1] published a study with 646 AKI hospital patients using RIFLE definition. They reported that patients who had an increment in SCr greater than 101% at the time of NC presented increased mortality and worse renal function at hospital discharge. However, neither PS nor further statistical analysis was performed, remaining uncertain about the influence of residual confounding factors.

Balasubramanian *et al.* [@pone.0070482-Balasubramanian1] demonstrated that early NC was associated with reduced risk of further decrease in kidney function (RIFLE criteria) in AKI hospital patients, considering a NC timing of 18 hours. For the first time, NC was assessed as an intervention in a randomized trial which probably provided a more powerful statistical analysis. However, informed consent was required for the patients, which might have induced selection bias for the attending physicians and nephrologists. Other limitations of this study were: pre-renal AKI was present in half of the sample; sepsis was the etiology in only one-third of the patients and dialysis requirement was observed in only 1% of the cases. These factors may explain the lack of association of early NC and mortality.

Recently, Ponce *et al.* [@pone.0070482-Ponce1] have published an observational, prospective study assessing 148 AKI ICU patients, in which only 77 patients were evaluated by nephrologists. Delayed NC, using a two-day interval, similarly was associated with increased mortality after adjustment in a multivariable analysis.

In our study, extended time to start RRT after AKI diagnosis was strongly associated with increased mortality. Although this study was not designed to assess decisions about dialysis indications, these data suggest that late RRT initiation may affect patients\' prognosis. Decisions about dialysis initiation in the ICU setting are influenced by several factors: time period after AKI diagnosis, AKI severity, AKI etiology, presence of chronic kidney dysfunction and other organ failures, illness severity, volume overload and nutritional status, mechanical ventilation demands, functional reserve (age, co-morbidities) and attending physicians\' preferences. An important issue of the present study is that RRT cannot be initiated without nephrology referral. Herein, ICU attending physician\'s perception about AKI severity and dialysis indication directly influenced nephrology referral and the timing of dialysis initiation.

Patients with delayed NC, regardless of dialysis requirement, presented higher mortality and longer mechanical ventilation support which could indicate either late nephrology intervention or worse patient\'s clinical status. Although propensity score for delayed NC should have corrected for these biases, we cannot propose that timing itself was responsible for the increased mortality risk.

Propensity score is an important statistical tool but it also has limitations [@pone.0070482-Austin3]--[@pone.0070482-Rubin2]. Variables included in the model were those statistically significant in the bivariate analysis but other important non-observed variables might have been excluded. Furthermore, this is a single center study and NC was performed by an experienced academic AKI-oriented group with great expertise in AKI management, with all available dialysis techniques that might not be available elsewhere.

The present study has also some strength. An association between delayed NC patients and increased mortality and worse renal function was demonstrated, even after correction for confounding variables in a relatively large group of critically ill AKI patients. Sepsis, the main AKI etiology, was present in almost 70% of patients. Data were collected by a single observer, avoiding inter-observer variability, and only a small group of patients (8.5%) was excluded because of missing data, minimizing selection and analysis biases. Despite of limitations of the propensity score model, it might be a valuable alternative to evaluate the influence of NC on AKI outcome. Alternatively, evaluation of nephrology intervention in AKI patients\' outcome in large randomized studies is hard to perform and to reproduce. Indeed, a recent pilot study has not brought better results [@pone.0070482-Balasubramanian1]. Furthermore, our study represents the situation of a routine medical practice in several countries worldwide in which early nephrologists\' interventions, including dialysis support, is dependent on ICU physicians\' referral to medical specialists and their perception of illness severity and priority.

In conclusion, in this group of critically ill AKI patients, around half of the patients were referred to nephrologists. Despite of the greater severity of NC patients compared to non-NC group, mortality rate was similar when adjusted by the propensity score. In contrast, delayed NC occurred in 34% of AKI patients and it was associated with increased mortality and dialysis dependence at hospital discharge, even after adjustment for confounding factors. A direct causal relationship could not be definitely established because some other factors, such as delayed recognition of severe AKI cases, residual confounding effects and the interface between nephrology and intensive care practice may have influenced these results. Herein, the best medical approach seems to be an early collaborative work between ICU physicians and nephrologists to share decisions and join experiences which could lead to interventions that may influence the critically ill AKI patients\' prognosis.

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.

[^2]: Conceived and designed the experiments: VTCS FL LY. Performed the experiments: VTCS IC. Analyzed the data: IC AM RD. Wrote the paper: VTCS FL LY.
